| Ytd | 48.35% | |
| 1y | 8.46% |
| Open | 3.61 | Prev Close | 3.60 | Low | 3.54 | High | 3.65 | Mkt Cap | 247.60M |
| Vol | 326.10K | Avg Vol | 529.05K | EPS | -0.69 | P/E | N/A | Forward P/E | -22.63 |
| Beta | 0.05 | Short Ratio | 1.91 | Inst. Own | 91.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 4.05 | 200-d Avg | 3.23 | 1yr Est | 6.00 |
OSUR News
https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidem
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its gu
OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $29.500 million-$32.500 million vs $31.143 milli
BETHLEHEM, Pa. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a lead
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announce
OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testi
The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the
BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OS
OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
OraSure Technologies (NASDAQ:OSUR) sees Q2 sales of $27.000 million-$30.000 million vs $29.098 milli
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.24) per share which missed the a
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader
BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has sch
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassi
OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report)'s share price crossed above its 200-day
Shares of OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day movi
Altai Capital urges board changes at OraSure, citing underperformance, governance concerns, and misa
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commerc
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commerc
LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. ("Altai"), one of the largest sharehold
Altai says OraSure is worth more sold than operating as a standalone companyAltai pressing for board
Activist investor Altai Capital Management called on OraSure Technologies to explore a sale, saying
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
OraSure Technologies (NASDAQ:OSUR) sees Q1 sales of $26.000 million-$29.000 million vs $28.599 milli
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the ana
OraSure Technologies (NASDAQ: OSUR - Get Free Report) and Agape ATP (NASDAQ: ATPC - Get Free Report)
The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada's first oral HI
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OS
BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has sche
OraSure Technologies, Inc. (NASDAQ:OSUR) ("OraSure" and "OTI"), a leader in point-of
Stephens & Co. analyst Steven Etoch maintains OraSure Technologies (NASDAQ:OSUR) with a Equal
Financial GuidanceThe Company is guiding to Q4 2025 Total revenues of $25 million to $28 million, wh
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.13) per share which beat the ana
Orasure stock price has dropped 11% in 4 weeks, 32% in 12 monthsZwanziger offered $3.50-$4 a share,
OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $27.000 million-$30.000 million vs $33.15 millio
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the ana
Evercore ISI Group analyst Vijay Kumar maintains OraSure Technologies (NASDAQ:OSUR) with a In-Lin
OraSure Technologies (NASDAQ:OSUR) sees Q2 sales of $28.500 million-$32.500 million vs $32.96 millio
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.18) per share which beat the ana
OraSure Technologies (NASDAQ:OSUR) sees Q1 sales of $27.500 million-$31.500 million vs $32.38 millio
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.06) per share which met the anal